It is currently unclear whether long-term treatment of patients with SCN will predispose patients to cytogenetic abnormalities, MDS or leukaemic transformation.
Det er aktuelt ikke afklaret, om langtidsbehandling af patienter med SCN gør disse patienter disponeret for cytogenetiske anomalier, myelodysplastiske syndromer eller leukæmisk transformation.